CPXCR1 Polyclonal Antibody, FITC Conjugated
- Size: 100ul
- Application: IF(IHC-P), IF(IHC-F), IF(ICC)
- Reactivity:
- Predicted Reactivity: Human, Horse
-
Datasheet Tech Support
PRODUCT DETAILS
SPECIFICATIONS |
|
---|---|
PRODUCT NAME |
CPXCR1 Polyclonal Antibody, FITC Conjugated |
CONJUGATION |
FITC |
HOST |
Rabbit |
SOURCE |
KLH conjugated synthetic peptide derived from human CPXCR1 |
IMMUNOGEN RANGE |
151-250/301 |
CLONALITY |
Polyclonal |
ISOTYPE |
IgG |
CONCENTRATION |
1ug/ul |
PURIFICATION |
Purified by Protein A. |
STORAGE BUFFER |
Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. |
STORAGE CONDITION |
Store at 4°C for 12 months. |
TARGET |
|
---|---|
GENE ID |
|
SUBCELLULAR LOCATION |
Cytoplasm, Nucleus, Secreted, Extracellular matrix |
SYNONYMS |
Cancer/testis antigen 77; CPX chromosome region, candidate 1; CPX candidate region 1 protein; CPX chromosomal region candidate gene 1 protein; CPX chromosomal region candidate gene 1 protein homolog; CPX chromosome region, candidate 1; CT77; Gm1143; CPXCR_HUMAN. |
BACKGROUND |
CPXCR1 is widely expressed in fetal tissues, including the tongue, mandible and palate with an unknown function. Cleft palate most commonly occurs as a sporadic multifactorial disorder with a clear but difficult to define genetic component. As a semi-dominant disorder, X-linked cleft palate (CPX) provides a useful model to investigate a congenital defect that is little influenced by non-genetic factors. |
APPLICATION DILUTION |
IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200) |